Found: 21
Select item for more details and to access through your institution.
Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 372, doi. 10.1159/000529173
- By:
- Publication type:
- Article
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 6, p. 561, doi. 10.1159/000518297
- By:
- Publication type:
- Article
Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?
- Published in:
- Clinical Colorectal Cancer, 2011, v. 10, n. 2, p. 73, doi. 10.1016/j.clcc.2011.03.001
- By:
- Publication type:
- Article
Erlotinib in the treatment of advanced pancreatic cancer.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 1, p. 83
- By:
- Publication type:
- Article
Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2019, v. 39, n. 8, p. 1468, doi. 10.1111/liv.14113
- By:
- Publication type:
- Article
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1825, doi. 10.1634/theoncologist.2020-0521
- By:
- Publication type:
- Article
An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 747, doi. 10.1634/theoncologist.2018-0838
- By:
- Publication type:
- Article
Hybrid Capture‐Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in BRCA1‐Mutant Cholangiocarcinoma Harboring a Novel YWHAZ‐BRAF Fusion.
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 998, doi. 10.1634/theoncologist.2017-0645
- By:
- Publication type:
- Article
Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
- Published in:
- Oncologist, 2017, v. 22, n. 7, p. 804, doi. 10.1634/theoncologist.2016-0415
- By:
- Publication type:
- Article
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Genomic profiling of combined hepatocellular‐cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
- Published in:
- Journal of Pathology, 2019, v. 248, n. 2, p. 164, doi. 10.1002/path.5243
- By:
- Publication type:
- Article
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myeloma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 9, p. 3059, doi. 10.1002/cam4.3880
- By:
- Publication type:
- Article
Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0222259
- By:
- Publication type:
- Article
Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 206, doi. 10.1186/s12885-015-1195-z
- By:
- Publication type:
- Article
Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 8, p. 2190, doi. 10.1002/ijc.33013
- By:
- Publication type:
- Article
Potent antitumor activity of cabozantinib, a c- MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 8, p. 1967, doi. 10.1002/ijc.29225
- By:
- Publication type:
- Article